Last updated on April 2016

Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases HRQoL and Comparison of Imaging Techniques


Brief description of study

Prospective observational study to assess bone predictive biomarkers for TKI response in RCC patients with bone metastasis and HRQoL with TKI in these patients as well as the sensitivity and specificity of whole body magnetic resonance versus bone scintigraphy and versus CT in the assessment of metastatic lesions at bone level and at other sites.

Detailed Study Description

Prospective observational study to assess: - Bone predictive biomarkers for tyrosine kinase inhibitor (TKI) response in renal cell carcinoma (RCC) patients with bone metastasis - Health Related Quality of Life (HRQoL) with TKI - Comparison of the sensitivity and specificity of whole body magnetic resonance versus bone scintigraphy and versus Computerized tomography (CT) in the assessment of metastatic lesions at bone level and at other sites.

Clinical Study Identifier: NCT02747173

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Serafin Costilla, MD

Hospital Universitario central de Asturias
Oviedo, Spain
  Connect »

Amaia Arrillaga, MD

Hospital de Donostia
San Sebastián, Spain
  Connect »

Roberto Garcia, MD

Complejo Hospitalario Univ de Santiago de Compostela
Santiago de Compostela, Spain
  Connect »

Carmen Sanchez, MD

Hospital de Navarra
Pamplona, Spain
  Connect »

Mercedes Arias, MD

Complejo Hospitalario Univ de Vigo
Vigo, Spain
  Connect »

Rafael Valls, MD

Consorcio Hospitalario Parc Tauli
Barcelona, Spain
  Connect »

Raquel Rueda, MD

Complejo Hospitalario de Le n
Leon, Spain
  Connect »

Sergio Vazquez, MD

Hospital Univ Lucus Augusti
Lugo, Spain
  Connect »

Ovidio Fernández

Complejo Hospitalario de Ourense
Ourense, Spain
  Connect »

Paula Pelechano, MD

Instituto Valenciano de Oncologia
Valencia, Spain
  Connect »

Isabel Elia, MD

Hospital Universitario La Fe
Valencia, Spain
  Connect »

Luis Sarria, MD

Hospital Miguel Servet
Zaragoza, Spain
  Connect »